Search

The article presents a case study of a 47-year-old man, who had developed type 1 immunological reaction while receiving rifampicin, clofazimine and dapsone for Mycobacterium leprae borderline lepromatous leprosy.

The article describes the cases of three patients with leprosy aged 63-86 years old who developed anemia and skin discoloration during treatment with clofazimine.

The article presents a case study of a 37-year-old woman with diffuse lepromatous leprosy which developed following treatment with lamivudine/abacavir and lopinavir/ritonavir.

An abstract of the article "Case Report of Two Cases of Fever, Rash, and Organ Involvement during the Treatment of Leprosy" by H. Liu and others is presented.

The article presents a case study of a 40-year-old female who was diagnosed with hypersensitivity pneumonitis after being medicated with dapsone for leprosy.

The article presents a case study of a 19-year-old boy who developed crystal-storing histiocytosis after being treated with clofazimine for leprosy.

The article presents a case study of an 11-year-old girl who developed fever and haemolytic anaemia after receiving dapsone for treating leprosy.

The article describes the case of a 30-year-old woman who developed crystalline deposition in the cornea and conjunctiva after receiving clofazimine for lepromatous leprosy.

Discusses research being done on the occurrence of cholangitis while under the dapsone therapy for suspected leprosy. Reference to a study by S. Itha et al, published in the August 11, 2003 issue of the "BMC Gastroenterology"; Side effects that manifested after starting the dapsone treatment; Results of a liver biopsy and skin biopsy conducted for the patient; Treatment received by the patient.